| . | CONV, n = 189 . | FT, n = 189 . | P-Value . |
|---|---|---|---|
| Biological prostheses, n (%) | 106 (56.1) | 134 (70.9) | 0.08 |
| Biological valved grafts, n (%) | |||
| Medtronic Freestyle Aortic Root Model 995 | 44 (23.2) | 39 (20.6) | |
| Vascutek BioValsalva Conduit | 2 (1.1) | 9 (4.8) | |
| SJM Toronto Root | 26 (13.8) | 3 (1.6) | |
| Biological prostheses used for ‘tailor-made‘ grafts, n (%) | |||
| CE Perimount Aortic Model 2900 | 28 (14.8) | 72 (38.1) | |
| CE Perimount Magna Ease Aortic Model 3300TFX | 4 (2.1) | 9 (4.8) | |
| Medtronic Mosaic Aortic Model 305 | 2 (1.1) | 2 (1.1) | |
| Mechanical prostheses, n (%) | 83 (43.9) | 55 (29.1) | 0.08 |
| Mechanical valved grafts, n (%) | |||
| ATS Aortic Valved Graft Model 502AG | 64 (33.9) | 46 (24.3) | |
| SJM Aortic Valved Graft Model CAVGJ-514 | 18 (9.5) | 9 (4.8) | |
| ATS Aortic Model 500FA Open Pivot as ‘tailor made’ graft, n (%) | 1 (0.5) | 0 (0) | |
| . | CONV, n = 189 . | FT, n = 189 . | P-Value . |
|---|---|---|---|
| Biological prostheses, n (%) | 106 (56.1) | 134 (70.9) | 0.08 |
| Biological valved grafts, n (%) | |||
| Medtronic Freestyle Aortic Root Model 995 | 44 (23.2) | 39 (20.6) | |
| Vascutek BioValsalva Conduit | 2 (1.1) | 9 (4.8) | |
| SJM Toronto Root | 26 (13.8) | 3 (1.6) | |
| Biological prostheses used for ‘tailor-made‘ grafts, n (%) | |||
| CE Perimount Aortic Model 2900 | 28 (14.8) | 72 (38.1) | |
| CE Perimount Magna Ease Aortic Model 3300TFX | 4 (2.1) | 9 (4.8) | |
| Medtronic Mosaic Aortic Model 305 | 2 (1.1) | 2 (1.1) | |
| Mechanical prostheses, n (%) | 83 (43.9) | 55 (29.1) | 0.08 |
| Mechanical valved grafts, n (%) | |||
| ATS Aortic Valved Graft Model 502AG | 64 (33.9) | 46 (24.3) | |
| SJM Aortic Valved Graft Model CAVGJ-514 | 18 (9.5) | 9 (4.8) | |
| ATS Aortic Model 500FA Open Pivot as ‘tailor made’ graft, n (%) | 1 (0.5) | 0 (0) | |
Categorical data: compared by McNemar’s chi-squared test with continuity correction; reported as numbers (percentages). P < 0.05 indicates statistical significance.
CONV: conventional treatment group; FT: fast-track treatment group.
| . | CONV, n = 189 . | FT, n = 189 . | P-Value . |
|---|---|---|---|
| Biological prostheses, n (%) | 106 (56.1) | 134 (70.9) | 0.08 |
| Biological valved grafts, n (%) | |||
| Medtronic Freestyle Aortic Root Model 995 | 44 (23.2) | 39 (20.6) | |
| Vascutek BioValsalva Conduit | 2 (1.1) | 9 (4.8) | |
| SJM Toronto Root | 26 (13.8) | 3 (1.6) | |
| Biological prostheses used for ‘tailor-made‘ grafts, n (%) | |||
| CE Perimount Aortic Model 2900 | 28 (14.8) | 72 (38.1) | |
| CE Perimount Magna Ease Aortic Model 3300TFX | 4 (2.1) | 9 (4.8) | |
| Medtronic Mosaic Aortic Model 305 | 2 (1.1) | 2 (1.1) | |
| Mechanical prostheses, n (%) | 83 (43.9) | 55 (29.1) | 0.08 |
| Mechanical valved grafts, n (%) | |||
| ATS Aortic Valved Graft Model 502AG | 64 (33.9) | 46 (24.3) | |
| SJM Aortic Valved Graft Model CAVGJ-514 | 18 (9.5) | 9 (4.8) | |
| ATS Aortic Model 500FA Open Pivot as ‘tailor made’ graft, n (%) | 1 (0.5) | 0 (0) | |
| . | CONV, n = 189 . | FT, n = 189 . | P-Value . |
|---|---|---|---|
| Biological prostheses, n (%) | 106 (56.1) | 134 (70.9) | 0.08 |
| Biological valved grafts, n (%) | |||
| Medtronic Freestyle Aortic Root Model 995 | 44 (23.2) | 39 (20.6) | |
| Vascutek BioValsalva Conduit | 2 (1.1) | 9 (4.8) | |
| SJM Toronto Root | 26 (13.8) | 3 (1.6) | |
| Biological prostheses used for ‘tailor-made‘ grafts, n (%) | |||
| CE Perimount Aortic Model 2900 | 28 (14.8) | 72 (38.1) | |
| CE Perimount Magna Ease Aortic Model 3300TFX | 4 (2.1) | 9 (4.8) | |
| Medtronic Mosaic Aortic Model 305 | 2 (1.1) | 2 (1.1) | |
| Mechanical prostheses, n (%) | 83 (43.9) | 55 (29.1) | 0.08 |
| Mechanical valved grafts, n (%) | |||
| ATS Aortic Valved Graft Model 502AG | 64 (33.9) | 46 (24.3) | |
| SJM Aortic Valved Graft Model CAVGJ-514 | 18 (9.5) | 9 (4.8) | |
| ATS Aortic Model 500FA Open Pivot as ‘tailor made’ graft, n (%) | 1 (0.5) | 0 (0) | |
Categorical data: compared by McNemar’s chi-squared test with continuity correction; reported as numbers (percentages). P < 0.05 indicates statistical significance.
CONV: conventional treatment group; FT: fast-track treatment group.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
